Literature DB >> 9321461

Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment.

D C Rogers1, E M Fisher, S D Brown, J Peters, A J Hunter, J E Martin.   

Abstract

For an understanding of the aberrant biology seen in mouse mutations and identification of more subtle phenotype variation, there is a need for a full clinical and pathological characterization of the animals. Although there has been some use of sophisticated techniques, the majority of behavioral and functional analyses in mice have been qualitative rather than quantitative in nature. There is, however, no comprehensive routine screening and testing protocol designed to identify and characterize phenotype variation or disorders associated with the mouse genome. We have developed the SHIRPA procedure to characterize the phenotype of mice in three stages. The primary screen utilizes standard methods to provide a behavioral and functional profile by observational assessment. The secondary screen involves a comprehensive behavioral assessment battery and pathological analysis. These protocols provide the framework for a general phenotype assessment that is suitable for a wide range of applications, including the characterization of spontaneous and induced mutants, the analysis of transgenic and gene-targeted phenotypes, and the definition of variation between strains. The tertiary screening stage described is tailored to the assessment of existing or potential models of neurological disease, as well as the assessment of phenotypic variability that may be the result of unknown genetic influences. SHIRPA utilizes standardized protocols for behavioral and functional assessment that provide a sensitive measure for quantifying phenotype expression in the mouse. These paradigms can be refined to test the function of specific neural pathways, which will, in turn, contribute to a greater understanding of neurological disorders.

Entities:  

Mesh:

Year:  1997        PMID: 9321461     DOI: 10.1007/s003359900551

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  256 in total

1.  Abnormal GABAA receptor-mediated currents in dorsal root ganglion neurons isolated from Na-K-2Cl cotransporter null mice.

Authors:  K W Sung; M Kirby; M P McDonald; D M Lovinger; E Delpire
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

2.  Welfare assessment in transgenic pigs expressing green fluorescent protein (GFP).

Authors:  Reinhard C Huber; Liliana Remuge; Ailsa Carlisle; Simon Lillico; Peter Sandøe; Dorte B Sørensen; C Bruce A Whitelaw; I Anna S Olsson
Journal:  Transgenic Res       Date:  2011-12-16       Impact factor: 2.788

3.  Changes in behaviors of male C57BL/6J mice across adult life span and effects of dietary restriction.

Authors:  Andreas Fahlström; Hugo Zeberg; Brun Ulfhake
Journal:  Age (Dordr)       Date:  2011-10-12

4.  Acquired infection with Toxoplasma gondii in adult mice results in sensorimotor deficits but normal cognitive behavior despite widespread brain pathology.

Authors:  Maria Gulinello; Mariana Acquarone; John H Kim; David C Spray; Helene S Barbosa; Rani Sellers; Herbert B Tanowitz; Louis M Weiss
Journal:  Microbes Infect       Date:  2010-03-27       Impact factor: 2.700

5.  p73 is an essential regulator of neural stem cell maintenance in embryonal and adult CNS neurogenesis.

Authors:  F Talos; A Abraham; A V Vaseva; L Holembowski; S E Tsirka; A Scheel; D Bode; M Dobbelstein; W Brück; U M Moll
Journal:  Cell Death Differ       Date:  2010-12       Impact factor: 15.828

6.  Human hepatocyte transplantation corrects the inherited metabolic liver disorder arginase deficiency in mice.

Authors:  Stephanie A K Angarita; Brian Truong; Suhail Khoja; Matthew Nitzahn; Abha K Rajbhandari; Irina Zhuravka; Sergio Duarte; Michael G Lin; Alex K Lam; Stephen D Cederbaum; Gerald S Lipshutz
Journal:  Mol Genet Metab       Date:  2018-04-21       Impact factor: 4.797

7.  Central CRTH2, a second prostaglandin D2 receptor, mediates emotional impairment in the lipopolysaccharide and tumor-induced sickness behavior model.

Authors:  Ryota Haba; Norihito Shintani; Yusuke Onaka; Takuya Kanoh; Hyper Wang; Risa Takenaga; Atsuko Hayata; Hiroyuki Hirai; Kin-ya Nagata; Masataka Nakamura; Atsushi Kasai; Ryota Hashimoto; Kazuki Nagayasu; Takanobu Nakazawa; Hitoshi Hashimoto; Akemichi Baba
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

Review 8.  Mouse models of genetic disease: new approaches, new paradigms.

Authors:  S D Brown
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

9.  Loss of ALS2 function is insufficient to trigger motor neuron degeneration in knock-out mice but predisposes neurons to oxidative stress.

Authors:  Huaibin Cai; Xian Lin; Chengsong Xie; Fiona M Laird; Chen Lai; Hongjin Wen; Hsueh-Cheng Chiang; Hoon Shim; Mohamed H Farah; Ahmet Hoke; Donald L Price; Philip C Wong
Journal:  J Neurosci       Date:  2005-08-17       Impact factor: 6.167

10.  Selective elimination of mitochondrial mutations in the germline by genome editing.

Authors:  Pradeep Reddy; Alejandro Ocampo; Keiichiro Suzuki; Jinping Luo; Sandra R Bacman; Sion L Williams; Atsushi Sugawara; Daiji Okamura; Yuji Tsunekawa; Jun Wu; David Lam; Xiong Xiong; Nuria Montserrat; Concepcion Rodriguez Esteban; Guang-Hui Liu; Ignacio Sancho-Martinez; Dolors Manau; Salva Civico; Francesc Cardellach; Maria Del Mar O'Callaghan; Jaime Campistol; Huimin Zhao; Josep M Campistol; Carlos T Moraes; Juan Carlos Izpisua Belmonte
Journal:  Cell       Date:  2015-04-23       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.